2003
Vascular Access Surveillance: Evaluation of Combining Dynamic Venous Pressure and Vascular Access Blood Flow Measurements
Hoeben H, Abu-Alfa AK, Reilly RF, Aruny JE, Bouman K, Perazella MA. Vascular Access Surveillance: Evaluation of Combining Dynamic Venous Pressure and Vascular Access Blood Flow Measurements. American Journal Of Nephrology 2003, 23: 403-408. PMID: 14566106, DOI: 10.1159/000074297.Peer-Reviewed Original ResearchConceptsArteriovenous fistulaArteriovenous graftsThrombosis rateThrombotic eventsVascular accessAccess blood flow measurementsSurveillance protocolBlood flow measurementsHemodialysis patientsVenous pressureDynamic venous pressureVascular access thrombosisChronic hemodialysis patientsAccess thrombosisEarly repairIntervention ratesBACKGROUND/Cutoff levelMorbid problemPatientsLow specificityAccess yearCombined monitoringStenosisThrombosis
1996
Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance?
Cruz D, Perazella M, Abu-Alfa A, Mahnensmith R. Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance? American Journal Of Kidney Diseases 1996, 28: 535-540. PMID: 8840943, DOI: 10.1016/s0272-6386(96)90464-3.Peer-Reviewed Original ResearchConceptsChronic hemodialysis patientsEnzyme inhibitor therapyACE inhibitorsHemodialysis patientsInhibitor therapySevere anemiaGroup 2Group 1End-stage renal diseaseExacerbation of anemiaSuppression of angiotensinChronic renal failureCongestive heart failureTherapy of anemiaBone marrow responseSignificant differencesRed blood cell productionRecombinant human EpoRHuEPO responseChronic hemodialysisErythropoietin resistanceRenal transplantationBaseline characteristicsHospital daysRenal failure